Actualización de los resultados de la rama española del Estudio aleatorizado europeo de screening del cáncer de próstata (ERSPC)
- 1 September 2015
- journal article
- research article
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 39 (7) , 405-413
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate CancerEuropean Urology, 2013
- Prostate Cancer Mortality in the Finnish Randomized Screening TrialJNCI: Journal of the National Cancer Institute, 2013
- Quality-of-Life Effects of Prostate-Specific Antigen ScreeningNew England Journal of Medicine, 2012
- Prostate-Cancer Mortality at 11 Years of Follow-upNew England Journal of Medicine, 2012
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-upJNCI: Journal of the National Cancer Institute, 2012
- Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic TestEuropean Urology, 2010
- Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)European Urology, 2009
- The effect of study arm on prostate cancer treatment in the large screening trial ERSPCInternational Journal of Cancer, 2009
- Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized Controlled TrialEuropean Urology, 2007
- Extent of Prostate-Specific Antigen Contamination in the Spanish Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)European Urology, 2006